{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T18:15:47Z","timestamp":1791137747518,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2011,2,17]],"date-time":"2011-02-17T00:00:00Z","timestamp":1297900800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1007\/s00415-011-5927-y","type":"journal-article","created":{"date-parts":[[2011,2,16]],"date-time":"2011-02-16T20:47:14Z","timestamp":1297889234000},"page":"1295-1303","source":"Crossref","is-referenced-by-count":41,"title":["Vascular risk factors are associated with faster decline of Alzheimer disease: a longitudinal SPECT study"],"prefix":"10.1007","volume":"258","author":[{"given":"Kazumasa","family":"Kume","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruo","family":"Hanyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiko","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Hirao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soichiro","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidekazu","family":"Kanetaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiofumi","family":"Sakurai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiko","family":"Iwamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,2,17]]},"reference":[{"key":"5927_CR1","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1212\/01.wnl.0000324925.95210.6d","volume":"71","author":"MS Beeri","year":"2008","unstructured":"Beeri MS, Schmeidler J, Silverman JM et al (2008) Insulin in combination with other diabetes medication is associated with less Alzheimer neuropathology. Neurology 71:750\u2013757","journal-title":"Neurology"},{"key":"5927_CR2","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1111\/j.1532-5415.2005.00512_4.x","volume":"53","author":"I Boksay","year":"2005","unstructured":"Boksay I, Reisberg B, Torossian C et al (2005) Alzheimer\u2019s disease and medical disease conditions: a prospective cohort study. J Am Geriatr Soc 53:2235\u20132236","journal-title":"J Am Geriatr Soc"},{"key":"5927_CR3","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1176\/appi.ajgp.12.6.554","volume":"12","author":"NJ Dougall","year":"2004","unstructured":"Dougall NJ, Bruggink S, Ebmeier KP (2004) Systematic review of the diagnostic accuracy of 99mTc-HMPAO-SPECT in dementia. Am J Geriatr Psychiatry 12:554\u2013570","journal-title":"Am J Geriatr Psychiatry"},{"key":"5927_CR4","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1212\/01.WNL.0000125323.15458.3F","volume":"62","author":"RM Evans","year":"2004","unstructured":"Evans RM, Hui S, Perkins A et al (2004) Cholesterol and APOE genotype interact to influence Alzheimer disease progression. Neurology 62:1869\u20131871","journal-title":"Neurology"},{"key":"5927_CR5","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR (1975) Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189\u2013198","journal-title":"J Psychiatr Res"},{"key":"5927_CR6","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1001\/archinte.162.18.2046","volume":"162","author":"F Forette","year":"2002","unstructured":"Forette F, Seux ML, Staessen JA et al (2002) Systolic hypertension in Europe investigators. The prevention of dementia with antihypertensive treatment. New evidence from the systolic hypertension in Europe (Syst-Eur) study. Arch Intern Med 162:2046\u20132052","journal-title":"Arch Intern Med"},{"key":"5927_CR7","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1212\/WNL.47.2.444","volume":"47","author":"JH Growdon","year":"1996","unstructured":"Growdon JH, Locascio JJ, Corkin S et al (1996) Apolipoprotein E genotype does not influence rates of cognitive decline in Alzheimer\u2019s disease. Neurology 47:444\u2013448","journal-title":"Neurology"},{"key":"5927_CR8","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1017\/S1041610200006359","volume":"12","author":"L Han","year":"2000","unstructured":"Han L, Cole M, Bellevance F et al (2000) Tracking cognitive decline in Alzheimer\u2019s disease using the mini-mental state examination: a meta-analysis. Int Psychogeriatr 12:231\u2013247","journal-title":"Int Psychogeriatr"},{"key":"5927_CR9","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1080\/01688639208402846","volume":"14","author":"JV Haxby","year":"1992","unstructured":"Haxby JV, Raffaele K, Gillette J et al (1992) Individual trajectories of cognitive decline in patients with dementia of the Alzheimer type. J Clin Exp Neuropsychol 14:575\u2013592","journal-title":"J Clin Exp Neuropsychol"},{"key":"5927_CR10","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1001\/archneur.66.3.343","volume":"66","author":"EP Helzner","year":"2009","unstructured":"Helzner EP, Luchsinger JA, Scarmeas N et al (2009) Contribution of vascular risk factors to the progression in Alzheimer disease. Arch Neurol 66:343\u2013348","journal-title":"Arch Neurol"},{"key":"5927_CR11","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1192\/bjp.140.6.566","volume":"140","author":"CP Highes","year":"1982","unstructured":"Highes CP, Berg L, Danzieger WL et al (1982) A new clinical scale for the staging of dementia. Br J Psychiatry 140:566\u2013572","journal-title":"Br J Psychiatry"},{"key":"5927_CR12","first-page":"548","volume":"42","author":"K Ishi","year":"2001","unstructured":"Ishi K, Willoch F, Minoshima S et al (2001) Statistical brain mapping of 18F-FDG PET in Alzheimer\u2019s disease: validation of anatomic standardization for atrophied brains. J Nucl Med 42:548\u2013557","journal-title":"J Nucl Med"},{"key":"5927_CR13","doi-asserted-by":"crossref","first-page":"149","DOI":"10.7326\/0003-4819-137-3-200208060-00006","volume":"137","author":"M Kivipelto","year":"2002","unstructured":"Kivipelto M, Helkala EL, Laakso MP et al (2002) Apolipoprotein E epsilon 4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease. Ann Intern Med 137:149\u2013155","journal-title":"Ann Intern Med"},{"key":"5927_CR14","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000093316","volume":"22","author":"T Kleiman","year":"2006","unstructured":"Kleiman T, Zdanys K, Black B et al (2006) Apolipoprotein E epsilon 4 allele is unrelated to cognitive or functional decline in Alzheimer\u2019s disease: retrospective and prospective analysis. Dement Geriatr Cogn Disord 22:73\u201382","journal-title":"Dement Geriatr Cogn Disord"},{"key":"5927_CR15","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0197-4580(00)00096-8","volume":"21","author":"LJ Launer","year":"2000","unstructured":"Launer LJ, Ross GW, Petrovitch H et al (2000) Midlife blood pressure and dementia: the Honolulu-Asia aging study. Neurobiol Aging 21:49\u201355","journal-title":"Neurobiol Aging"},{"key":"5927_CR16","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1212\/01.wnl.0000277657.95487.1c","volume":"69","author":"G Li","year":"2007","unstructured":"Li G, Larson EB, Sonnen JA et al (2007) Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease. Neurology 69:878\u2013885","journal-title":"Neurology"},{"key":"5927_CR17","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","volume":"34","author":"G McKhann","year":"1984","unstructured":"McKhann G, Drachman D, Folstein M et al (1984) Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s disease. Neurology 34:939\u2013944","journal-title":"Neurology"},{"key":"5927_CR18","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1212\/01.wnl.0000279520.59792.fe","volume":"69","author":"MM Mielke","year":"2007","unstructured":"Mielke MM, Rosenberg PB, Tschanz J et al (2007) Vascular factors predict rate of progression in Alzheimer disease. Neurology 69:1850\u20131858","journal-title":"Neurology"},{"key":"5927_CR19","first-page":"1528","volume":"35","author":"S Minoshima","year":"1994","unstructured":"Minoshima S, Koeppe RA, Frey KA et al (1994) Anatomic standardization: linear scaling and nonlinear warping of functional brain images. J Nucl Med 35:1528\u20131537","journal-title":"J Nucl Med"},{"key":"5927_CR20","first-page":"1238","volume":"36","author":"S Minoshima","year":"1995","unstructured":"Minoshima S, Frey KA, Koeppe RA et al (1995) A diagnostic approach in Alzheimer\u2019s disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J Nucl Med 36:1238\u20131248","journal-title":"J Nucl Med"},{"key":"5927_CR21","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/BF02988523","volume":"17","author":"S Mizumura","year":"2003","unstructured":"Mizumura S, Kumita S, Cho K et al (2003) Development of quantitative analysis method for stereotactic brain image: assessment of reduced accumulation in extent and severity using anatomical segmentation. Ann Nucl Med 17:289\u2013295","journal-title":"Ann Nucl Med"},{"key":"5927_CR22","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1176\/ajp.154.5.603","volume":"154","author":"GM Murphy Jr","year":"1997","unstructured":"Murphy GM Jr, Taylor J, Kraemer HC et al (1997) No association between apolipoprotein E epsilon 4 allele and rate of decline in Alzheimer\u2019s disease. Am J Psychiatry 154:603\u2013608","journal-title":"Am J Psychiatry"},{"key":"5927_CR23","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1007\/s00415-009-5116-4","volume":"256","author":"M Musicco","year":"2009","unstructured":"Musicco M, Palmer K, Salamone G et al (2009) Predictors of progression of cognitive decline in Alzheimer\u2019s disease: the role of vascular and sociodemographic factors. J Neurol 256:1288\u20131295","journal-title":"J Neurol"},{"key":"5927_CR24","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000026149","volume":"17","author":"IL Notkola","year":"1998","unstructured":"Notkola IL, Sulkava R, Pekkanen J et al (1998) Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer\u2019s disease. Neuroepidemiology 17:14\u201320","journal-title":"Neuroepidemiology"},{"key":"5927_CR25","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1212\/01.WNL.0000140705.23869.E9","volume":"63","author":"T Ohrui","year":"2004","unstructured":"Ohrui T, Tomita N, Sato-Nakagawa T et al (2004) Effects of brain-penetrating ACE inhibitors on Alzheimer disease progression. Neurology 63:1324\u20131325","journal-title":"Neurology"},{"key":"5927_CR26","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1212\/WNL.53.9.1937","volume":"53","author":"A Ott","year":"1999","unstructured":"Ott A, Stolk RP, van Harskamp F et al (1999) Diabetes mellitus and the risk of dementia: the rotterdam study. Neurology 53:1937\u20131942","journal-title":"Neurology"},{"key":"5927_CR27","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1212\/01.wnl.0000240129.46080.53","volume":"67","author":"C Regan","year":"2006","unstructured":"Regan C, Katona C, Walker Z et al (2006) Relationship of vascular risk to the progression of Alzheimer disease. Neurology 67:1357\u20131362","journal-title":"Neurology"},{"key":"5927_CR28","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1749-6632.1984.tb13859.x","volume":"485","author":"B Reisberg","year":"1984","unstructured":"Reisberg B, Ferris SH, Anand R et al (1984) Functional staging of dementia of the Alzheimer\u2019s type. Ann NY Scad Sci 485:481\u2013483","journal-title":"Ann NY Scad Sci"},{"key":"5927_CR29","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/sj.tpj.6500369","volume":"6","author":"ME Risner","year":"2006","unstructured":"Risner ME, Saunders AM, Altman JF et al (2006) Rosiglitazone in Alzheimer\u2019s Disease Study Group. Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer\u2019s disease. Pharmacogenom J 6:246\u2013254","journal-title":"Pharmacogenom J"},{"key":"5927_CR30","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.clineuro.2008.10.006","volume":"111","author":"F Roselli","year":"2009","unstructured":"Roselli F, Tartaglione B, Federico F et al (2009) Rate of MMSE score change in Alzheimer\u2019s disease: influence of education and vascular risk factors. Clin Neurol Neurosurg 111:327\u2013330","journal-title":"Clin Neurol Neurosurg"},{"key":"5927_CR31","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1212\/WNL.0b013e3181bd80e9","volume":"73","author":"C Sanz","year":"2009","unstructured":"Sanz C, Andrieu S, Sinclair A et al (2009) Diabetes is associated with a slower rate of cognitive decline in Alzheimer disease. Neurology 73:1359\u20131366","journal-title":"Neurology"},{"key":"5927_CR32","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S0140-6736(96)90608-X","volume":"347","author":"I Skoog","year":"1996","unstructured":"Skoog I, Lernfelt B, Landahl S et al (1996) A 15-year longitudinal study of blood pressure and dementia. Lancet 347:1141\u20131145","journal-title":"Lancet"},{"key":"5927_CR33","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.amjhyper.2005.02.013","volume":"18","author":"I Skoog","year":"2005","unstructured":"Skoog I, Lithell H, Hansson L et al (2005) Effect of baseline cognitive function and antihypertensive treatment on cognitive and cardiovascular outcomes: study on cognition and prognosis in the elderly (SCOPE). Am J Hypertens 18:1052\u20131059","journal-title":"Am J Hypertens"},{"key":"5927_CR34","volume-title":"Co-planar stereotactic atlas of the human brain","author":"J Talairach","year":"1998","unstructured":"Talairach J, Tournoux P (1998) Co-planar stereotactic atlas of the human brain. New York, Thieme"},{"key":"5927_CR35","unstructured":"The Japan Atherosclerotic Society (2007) Guidelines for prevention of atherosclerotic cardiovascular diseases. Kyowakikaku, Tokyo"},{"key":"5927_CR36","unstructured":"The Japan Diabetic Society (2010) Treatment Guide for Diabetes. Bunkodo, Tokyo"},{"key":"5927_CR37","unstructured":"The Japanese Society of Hypertension (2009) Guidelines for the management of hypertension. Life Science, Tokyo"},{"key":"5927_CR38","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1159\/000203365","volume":"27","author":"GA Kan van","year":"2009","unstructured":"van Kan GA, Rolland Y, Nourhashemi F et al (2009) Cardiovascular disease risk factors and progression of Alzheimer\u2019s disease. Dement Geriatr Cogn Disord 27:240\u2013246","journal-title":"Dement Geriatr Cogn Disord"},{"key":"5927_CR39","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1212\/WNL.45.6.1161","volume":"45","author":"T Yoshitake","year":"1995","unstructured":"Yoshitake T, Kiyohara Y, Kato I et al (1995) Incidence and risk factors of vascular dementia and Alzheimer\u2019s disease in a defined elderly Japanese population: the Hisayama study. Neurology 45:1161\u20131168","journal-title":"Neurology"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-011-5927-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-011-5927-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-011-5927-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T15:53:18Z","timestamp":1560009198000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-011-5927-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,17]]},"references-count":39,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["5927"],"URL":"https:\/\/doi.org\/10.1007\/s00415-011-5927-y","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,17]]}}}